ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36785
0.00%
Bitcoin
60,902.72
0.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) News

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNCE
DateTimeSourceHeadlineSymbolCompany
03/16/20238:02AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/14/20235:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/14/20235:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/14/20235:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/14/20235:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:58AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:53AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:41AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:41AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:38AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:34AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:33AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:29AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:26AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/202310:23AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/20238:47AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/20238:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/06/20238:01AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/24/20233:06PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/24/20233:03PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/16/20237:52AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/16/20237:49AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/16/20237:48AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/15/20236:00AMBusiness WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
02/14/20234:07PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/14/20231:36PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/13/20238:26AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Your Recent History

USOTC
TXTM
ProText Mobility (PK)
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
RDAR
Raadr (PK)
USOTC
VDRM
ViaDerma (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
PHIL
PHI (PK)
USOTC
TDRK
TideRock Companies (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved